Ftse Mib
33.629,21
-0,32%
DAX
18.001,60
0,54%
S&P 500
5.127,79
1,26%
NASDAQ
16.156,33
1,99%
Bitcoin
63.429,70
0,87%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Lexaria Bioscience Corporation (LEXX) Lexaria Bioscience Corporation (LEXX) Notizie

Lexaria Bioscience Corporation

LEXX
3,21
0,21 (7,00%)
04 Mag 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
06/3/202412:00EDGAR2Form DEF 14A - Other definitive proxy statements
01/3/202420:28EDGAR2Form 8-K - Current report
16/2/202422:30EDGAR2Form 8-K - Current report
16/2/202421:47EDGAR2Form D - Notice of Exempt Offering of Securities
14/2/202420:20EDGAR2Form SC 13D/A - General statement of acquisition of..
14/2/202418:00EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
30/1/202419:51EDGAR2Form 8-K - Current report
24/1/202420:12EDGAR2Form 8-K - Current report
24/1/202419:33EDGAR2Form POS AM - Post-Effective amendments for registration..
18/1/202420:38EDGAR2Form S-8 - Securities to be offered to employees in employee..
12/1/202423:11EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/1/202414:30GLOBELexaria Bioscience Corp. (NASDAQ: LEXX) Proprietary..
10/1/202414:45IHNWGLP-1: Beyond Diabetes, a Blockbuster Horizon Beckons
09/1/202414:30GLOBELexaria Bioscience Corp. (NASDAQ: LEXX) Improves Delivery,..
08/1/202414:45IHNWExciting New Cures Possible from GLP-1 Diabetes, Weight-Loss..
04/1/202423:07EDGAR2Form 8-K - Current report
30/11/202322:14EDGAR2Form S-1 - General form for registration of securities under..
20/11/202323:16EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
03/11/202318:13EDGAR2Form 8-K - Current report
01/11/202318:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/11/202313:45IHNWGet Ready for Next Generation of Diabetes, Weight-Management..
01/11/202313:30GLOBELexaria Bioscience Corp. (NASDAQ: LEXX) Expands Studies of..
31/10/202313:31GLOBELexaria Bioscience Corp. (NASDAQ: LEXX) Evaluating..
30/10/202317:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/10/202313:45IHNWCan Diabetes, Weight-Loss Drugs Get Even Better?
18/10/202318:25EDGAR2Form 8-K - Current report
16/10/202319:13EDGAR2Form 8-K - Current report
12/10/202321:57EDGAR2Form 8-K - Current report
03/10/202322:05EDGAR2Form 8-K - Current report
28/8/202320:50EDGAR2Form 8-K - Current report
28/7/202318:11EDGAR2Form 8-K - Current report
25/7/202320:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/7/202319:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/7/202322:00EDGAR2Form 8-K - Current report
14/7/202320:42EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Apertura: 3,05 Min: 2,93 Max: 3,24
Chiusura: 3,00

La tua Cronologia

NASDAQ
LEXX
Lexaria Bioscience
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network